Genome sequencing detects a balanced pericentric inversion with breakpoints that impact the DMD and upstream region of POU3F4 genes

Am J Med Genet A. 2024 Mar;194(3):e63462. doi: 10.1002/ajmg.a.63462. Epub 2023 Nov 6.

Abstract

We describe a family with two maternal half-brothers both of whom presented with muscular dystrophy, autism spectrum disorder, developmental delay, and sensorineural hearing loss. The elder brother had onset of features at ~3 months of age, followed by clinical confirmation of muscular dystrophy at 3 years. Skeletal biopsy staining at 4.7 years showed an absence of dystrophin protein which prompted extensive molecular testing over 4 years that included gene panels, targeted single-gene assays, arrays, and karyotyping, all of which failed to identify a clinically significant variant in the DMD gene. At 10 years of age, clinical whole-genome sequencing (cWGS) was performed, which revealed a novel hemizygous ~50.7 Mb balanced pericentric inversion on chromosome X that disrupts the DMD gene in both siblings, consistent with the muscular dystrophy phenotype. This inversion also impacts the upstream regulatory region of POU3F4, structural rearrangements which are known to cause hearing loss. The unaffected mother is a heterozygous carrier for the pericentric inversion. This finding illustrates the ability of cWGS to detect a wide breadth of disease-causing genomic variations including large genomic rearrangements.

Keywords: DMD; balanced inversion; cWGS; complex diagnosis; dystrophinopathy.

Publication types

  • Case Reports

MeSH terms

  • Autism Spectrum Disorder* / genetics
  • Base Sequence
  • Child, Preschool
  • Chromosome Inversion / genetics
  • Dystrophin / genetics
  • Female
  • Humans
  • Male
  • Muscular Dystrophies* / genetics
  • Muscular Dystrophy, Duchenne* / genetics
  • POU Domain Factors / genetics

Substances

  • Dystrophin
  • POU Domain Factors
  • POU3F4 protein, human
  • DMD protein, human